Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
March 21st, 2021
11.7K views
Segmentation and linear measurements quantify skeletal muscle mass and adipose tissues using Computed Tomography and/or Magnetic Resonance Imaging images. Here, we outline the use of Slice-O-Matic software and Horos image viewer for rapid and accurate analysis of body composition. These methods can provide important information for prognosis and risk stratification.
Overview
This article discusses the quantification of skeletal muscle mass and adipose tissues using imaging techniques such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). It highlights the use of Slice-O-Matic software and Horos image viewer for efficient body composition analysis.
Key Study Components
Area of Science
- Neuroscience
- Medical Imaging
- Body Composition Analysis
Background
- Ribbon muscle degeneration is a prognostic factor for cancer survival.
- Analysis of the third lumbar region (L3) provides insights into skeletal muscle and adipose tissue.
- Different software tools may be used for segmentation and analysis.
- CT scans offer qualitative information about adipose tissue.
Purpose of Study
- To outline protocols for analyzing body composition from CT and MRI images.
- To provide detailed segmentation methods using Slice-O-Matic software.
- To enhance accuracy in measuring skeletal muscle and adipose tissues.
Methods Used
- Utilization of Slice-O-Matic for segmentation of muscle and fat tissues.
- Step-by-step protocol for selecting and exporting images from CT/MRI scans.
- Setting H.U. limits for different tissue types during segmentation.
- Tagging and verifying muscle and adipose tissues to ensure accurate analysis.
Main Results
- Successful segmentation of skeletal muscle and adipose tissues using specified H.U. limits.
- Accurate measurement of surface area and average H.U. values for each tissue type.
- Demonstrated effectiveness of the outlined methods for body composition analysis.
- Identified challenges in segmenting adipose tissue from MRI images.
Conclusions
- The methods described provide a reliable approach for body composition analysis.
- Utilizing appropriate software tools enhances the accuracy of segmentation.
- Further research may improve the discrimination of adipose tissue in MRI scans.
Frequently Asked Questions
What imaging techniques are discussed in the article?
The article discusses Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) techniques.
What software is recommended for body composition analysis?
Slice-O-Matic and Horos image viewer are recommended for rapid and accurate analysis.
Why is the analysis of the third lumbar region important?
It provides quantitative characterization of skeletal muscle and qualitative information about adipose tissue.
What are H.U. limits?
H.U. limits refer to Hounsfield Units, which are used to differentiate between various tissue types in imaging.
Can these methods be applied to other imaging software?
While the methods are outlined for Slice-O-Matic, similar principles can be applied to other imaging software with appropriate adjustments.
What is the significance of tagging in the segmentation process?
Tagging ensures that specific tissues are accurately identified and measured during the analysis.
Executive Industry Relevance
Accurate body composition analysis from CT and MRI scans supports preclinical and translational research by quantifying skeletal muscle and adipose tissue depots. These measurements enable mechanistic de-risking in disease models where sarcopenia or adiposity influences therapeutic response. The methods provide quantitative biomarkers for patient stratification and treatment outcome prediction in oncology and metabolic disease pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses linking muscle or fat mass to disease progression.
- Operational Value: Provides quantitative tissue segmentation for functional target validation in preclinical models.
Screening & Assay Development
- Scientific Value: Delivers standardized, reproducible tissue surface area measurements for assay readiness.
- Operational Value: Supports scalable workflows using Slice-O-Matic or Horos for high-throughput imaging analysis.
Translational & Preclinical Research
- Scientific Value: Facilitates disease-relevant system modeling by correlating L3-derived metrics with pathological phenotypes.
- Operational Value: Ensures continuity from discovery imaging to preclinical validation through consistent body composition quantification.
Pipeline & Workflow Integration
The method integrates into discovery biology workflows by providing quantitative imaging endpoints that inform lead identification and preclinical advancement decisions.
- Discovery Biology: Supports hypothesis testing via precise segmentation of muscle and adipose tissues from CT/MRI.
- Screening: Enables assay standardization through reproducible H.U.-based tagging and surface area quantification.
- Analytics: Generates quantitative dependent variables (tissue area, H.U. values) for cross-condition comparison.
- Translational Research: Connects to preclinical continuity by providing translatable biomarkers from patient imaging.
- Enterprise Reuse: Establishes a reusable imaging capability for body composition analysis across therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in muscle-fat interactions.
- Operational Value: Enhances reproducibility and scalability of imaging-based phenotyping.
- Strategic Value: Improves go/no-go decisions through objective, quantifiable biomarkers.
- Portfolio Impact: Enables risk-adjusted prioritization based on body composition correlates of treatment response.
Implementation Considerations
- Requires expertise in medical image interpretation and tissue annotation.
- Dependent on DICOM-compatible imaging infrastructure and segmentation software (Slice-O-Matic, Horos).
- Necessitates cross-team standardization of H.U. limits and tagging protocols.
- Involves adaptation considerations for MRI vs. CT adipose tissue discrimination limitations.
- Limited by time-intensive segmentation and training requirements for comprehensive tissue analysis.
Biopharma FAQs
Why does segmentation of skeletal muscle and adipose tissue matter for target validation?
Segmentation enables precise quantification of tissue-specific changes in response to therapeutic interventions, supporting mechanistic de-risking in preclinical studies. It provides quantitative endpoints to correlate target engagement with alterations in muscle or fat mass. This enhances target validation by linking molecular effects to phenotypic outcomes in disease-relevant systems.
How does isolating the L3 vertebral level as an independent variable fit the discovery pipeline?
Using the L3 level standardizes anatomical positioning across subjects, reducing variability in body composition measurements. This consistency enables reliable comparison of skeletal muscle and adipose tissue metrics in preclinical and clinical cohorts. Standardization supports assay reproducibility and cross-functional collaboration in target validation workflows.
What quantitative dependent variable measurements enable body composition analysis?
Surface area measurements of skeletal muscle, intramuscular adipose, visceral adipose, and subcutaneous adipose tissues serve as key dependent variables. These are derived from tag surface area functions in Slice-O-Matic after H.U.-based tissue segmentation. The measurements provide quantitative inputs for correlating with disease progression or treatment response.
Why do replication requirements matter for cross-functional collaboration in imaging analysis?
Replication ensures that segmentation and linear measurement protocols yield consistent results across operators, software, and imaging platforms. This consistency is essential for generating reliable data that inform go/no-go decisions in drug development. Standardized replication supports data sharing between discovery, translational, and clinical teams.
What statistical analysis capabilities are required before implementing L3-based body composition analysis?
Teams require the ability to correlate tissue surface area or linear measurement indices with clinical or phenotypic endpoints. Statistical tools must support regression, correlation, and group comparison analyses to assess predictive value. These capabilities enable risk-stratified advancement decisions based on body composition biomarkers.
